Latest news
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation - TMX NewsfileTMX Newsfile · Fri, 07 Aug 2026 16:45:00 GMTFULC Stock Slumps Nearly 50% After Hours As FDA Kills Only Clinical Program Over Cancer Risk - StocktwitsStocktwits · Fri, 07 Aug 2026 14:37:02 GMTFulcrum Therapeutics Inc (FULC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:00:02 GMTFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:29:58 GMTFulcrum Therapeutics (FULC) Stock Sees Modest Fair Value Lift After Pociredir Exit - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 08:12:22 GMTBank of America (NYSE: BAC) reports 6.7% holding in Fulcrum Therapeutics (FULC) - Stock TitanStock Titan · Mon, 03 Aug 2026 16:13:03 GMTTruist Financial Downgrades Fulcrum Therapeutics(FULC.US) to Hold Rating, Cuts Target Price to $4 - MoomooMoomoo · Fri, 31 Jul 2026 12:34:00 GMTFulcrum Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 31 Jul 2026 08:13:30 GMT